Global market valuation was derived through revenue mapping, unit volume analysis, and procedure volume assessment. The methodology included:
Identification of 45+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in eyeglasses, contact lenses, intraocular lenses, lens care solutions, and ophthalmic pharmaceuticals
Product mapping across soft contact lenses (spherical, toric, multifocal), rigid gas permeable lenses, myopia control devices, premium intraocular lenses (monofocal, multifocal, toric, EDOF), spectacle lenses (single vision, progressive, photochromic), and over-the-counter eye drops
Analysis of reported and modeled annual revenues specific to vision care portfolios of diversified healthcare conglomerates and pure-play eyewear companies
Coverage of manufacturers representing 70-75% of global market share in 2024, including comprehensive data from EssilorLuxottica, Johnson & Johnson Vision, Alcon, Bausch + Lomb, The Cooper Companies, Carl Zeiss Meditec, HOYA Corporation, and Menicon
Extrapolation using bottom-up (contact lens fits × ASP, spectacle unit sales × lens pricing, cataract procedures × IOL ASP by country) and top-down (manufacturer revenue validation and optical retail channel checks) approaches to derive segment-specific valuations for refractive correction, surgical vision care, and contact lens solutions